Marie-Christine Mowinckel

  • Bioingineer; MSc
  • +47 23 07 21 84
 

Publications 2023

Harrison SP, Siller R, Tanaka Y, Chollet ME, de la Morena-Barrio ME, Xiang Y, Patterson B, Andersen E, Bravo-Pérez C, Kempf H, Åsrud KS, Lunov O, Dejneka A, Mowinckel MC, Stavik B, Sandset PM, Melum E, Baumgarten S, Bonanini F, Kurek D, Mathapati S, Almaas R, Sharma K, Wilson SR, Skottvoll FS et al. (2023)
Scalable production of tissue-like vascularized liver organoids from human PSCs
Exp Mol Med, 55 (9), 2005-2024
DOI 10.1038/s12276-023-01074-1, PubMed 37653039

Publications 2022

Garabet L, Eriksson A, Tjønnfjord E, Cui XY, Olsen MK, Jacobsen HK, Jørgensen CT, Mathisen ÅB, Mowinckel MC, Ahlen MT, Sørvoll IH, Horvei KD, Ernstsen SL, Lægreid IJ, Stavik B, Holst R, Sandset PM, Ghanima W (2022)
SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
Res Pract Thromb Haemost, 7 (1), 100002
DOI 10.1016/j.rpth.2022.100002, PubMed 36448024

Publications 2021

Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
TH Open, 5 (1), e14-e23
DOI 10.1055/s-0040-1721782, PubMed 33564742

Publications 2020

Andersen NG, Mowinckel MC, Sunde K, Sandset PM, Beitland S (2020)
Utility of coagulation analyses to assess thromboprophylaxis with dalteparin in intensive care unit patients
Acta Anaesthesiol Scand, 65 (4), 489-498
DOI 10.1111/aas.13748, PubMed 33205407

Publications 2019

Eilertsen AL, Dahm AEA, Høibraaten E, Lofthus CM, Mowinckel MC, Sandset PM (2019)
Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment
Blood Coagul Fibrinolysis, 30 (1), 17-23
DOI 10.1097/MBC.0000000000000784, PubMed 30507711

Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernández-Pérez MP, Martínez C, González-Conejero R, Mowinckel MC, Sandset PM (2019)
Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists
Thromb Res, 185, 119-124
DOI 10.1016/j.thromres.2019.11.031, PubMed 31805421

Gregersen I, Høibraaten E, Holven KB, Løvdahl L, Ueland T, Mowinckel MC, Dahl TB, Aukrust P, Halvorsen B, Sandset PM (2019)
Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women
Thromb Res, 184, 1-7
DOI 10.1016/j.thromres.2019.10.005, PubMed 31677448

Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
Thromb Res, 177, 154-156
DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875

Publications 2018

Kostovski E, Frigato E, Savikj M, Dahm A, Sandset PM, Mowinckel MC, Skretting G, Østerud B, Bertolucci C, Iversen PO (2018)
Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation
Spinal Cord, 56 (11), 1076-1083
DOI 10.1038/s41393-018-0176-x, PubMed 29985456

Publications 2017

Garabet L, Ghanima W, Monceyron Jonassen C, Skov V, Holst R, Mowinckel MC, C Hasselbalch H, A Kruse T, Thomassen M, Liebman H, Bussel JB, Sandset PM (2017)
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia
Platelets, 30 (2), 206-212
DOI 10.1080/09537104.2017.1394451, PubMed 29215956

Publications 2016

Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM (2016)
Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
Scand J Immunol, 84 (2), 95-9
DOI 10.1111/sji.12445, PubMed 27135178

Tinholt M, Sandset PM, Mowinckel MC, Garred Ø, Sahlberg KK, Kristensen VN, Børresen-Dale AL, Jacobsen AF, Skretting G, Iversen N (2016)
Determinants of acquired activated protein C resistance and D-dimer in breast cancer
Thromb Res, 145, 78-83
DOI 10.1016/j.thromres.2016.08.003, PubMed 27505249

Publications 2015

Iversen PO, Dahm A, Skretting G, Mowinckel MC, Stranda A, Østerud B, Sandset PM, Kostovski E (2015)
Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study
Thromb Haemost, 114 (5), 964-8
DOI 10.1160/TH15-05-0396, PubMed 26202881

Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO (2015)
Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
Spinal Cord, 53 (4), 285-90
DOI 10.1038/sc.2014.243, PubMed 25644388

Wik HS, Jacobsen AF, Mowinckel MC, Sandset PM (2015)
The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: A population-based, cross-sectional study
Thromb Res, 138, 16-21
DOI 10.1016/j.thromres.2015.12.014, PubMed 26826503

Publications 2014

Pitkänen H, Jouppila A, Mowinckel MC, Lemponen M, Patiwael S, Sandset PM, Lassila R, Brinkman HJ (2014)
Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
Thromb Res, 135 (1), 167-74
DOI 10.1016/j.thromres.2014.10.020, PubMed 25466844

Publications 2012

Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM (2012)
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
Thromb Res, 130 (1), 45-51
DOI 10.1016/j.thromres.2011.12.009, PubMed 22217510

Publications 2011

Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
Br J Haematol, 154 (2), 241-7
DOI 10.1111/j.1365-2141.2011.08712.x, PubMed 21564075

Publications 2008

Negaard HF, Iversen PO, Ostenstad B, Mowinckel MC, Sandset PM (2008)
Increased acquired activated protein C resistance in unselected patients with hematological malignancies
J Thromb Haemost, 6 (9), 1482-7
DOI 10.1111/j.1538-7836.2008.03060.x, PubMed 18573186

Publications 2007

Eilertsen AL, Liestøl S, Mowinckel MC, Hemker HC, Sandset PM (2007)
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system
Thromb Haemost, 97 (6), 938-43
DOI 10.1160/TH06-11-0632, PubMed 17549295

Liestøl S, Sandset PM, Mowinckel MC, Wisløff F (2007)
Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
J Thromb Haemost, 5 (11), 2204-10
DOI 10.1111/j.1538-7836.2007.02734.x, PubMed 17958739

Publications 2006

Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM (2006)
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis
Thromb Res, 120 (3), 371-9
DOI 10.1016/j.thromres.2006.10.013, PubMed 17156824

Ghanima W, Abdelnoor M, Mowinckel MC, Sandset PM (2006)
The performance of STA-Liatest D-dimer assay in out-patients with suspected pulmonary embolism
Br J Haematol, 132 (2), 210-5
DOI 10.1111/j.1365-2141.2005.05859.x, PubMed 16398655

Liestøl S, Sandset PM, Jacobsen EM, Mowinckel MC, Wisløff F (2006)
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
Br J Haematol, 136 (1), 131-7
DOI 10.1111/j.1365-2141.2006.06385.x, PubMed 17092306

Publications 2004

Andersen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
The ability of three global plasma assays to recognize thrombophilia
In Thrombosis research, Pergamon Press, New York, 113(2004)6, S. 411-17
BIBSYS 051896508

Andresen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
The ability of three global plasma assays to recognize thrombophilia
Thromb Res, 113 (6), 411-7
DOI 10.1016/j.thromres.2004.05.002, PubMed 15226097

Publications 2002

Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM (2002)
Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia
Br J Haematol, 119 (4), 1011-6
DOI 10.1046/j.1365-2141.2002.03953.x, PubMed 12472582

Publications 2001

Høibraaten E, Mowinckel MC, de Ronde H, Bertina RM, Sandset PM (2001)
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial
Br J Haematol, 115 (2), 415-20
DOI 10.1046/j.1365-2141.2001.03111.x, PubMed 11703344

Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM (2001)
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial
Thromb Haemost, 85 (5), 775-81
PubMed 11372667

Publications 1996

Andersson T, Lorentzen B, Hogdahl H, Clausen T, Mowinckel MC, Abildgaard U (1996)
Thrombin-inhibitor complexes in the blood during and after delivery
Thromb Res, 82 (2), 109-17
DOI 10.1016/0049-3848(96)00057-6, PubMed 9163064

Mourão PA, Pereira MS, Pavão MS, Mulloy B, Tollefsen DM, Mowinckel MC, Abildgaard U (1996)
Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm. Sulfated fucose branches on the polysaccharide account for its high anticoagulant action
J Biol Chem, 271 (39), 23973-84
DOI 10.1074/jbc.271.39.23973, PubMed 8798631

Whitelaw A, Mowinckel MC, Fellman V, Abildgaard U (1996)
Endogenous tissue plasminogen activator in neonatal cerebrospinal fluid
Eur J Pediatr, 155 (2), 117-9
DOI 10.1007/BF02075763, PubMed 8775226

Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N (1996)
Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus
Arch Dis Child Fetal Neonatal Ed, 75 (1), F20-6
DOI 10.1136/fn.75.1.f20, PubMed 8795351

Publications 1995

Whitelaw A, Mowinckel MC, Abildgaard U (1995)
Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?
Acta Paediatr, 84 (8), 933-6
DOI 10.1111/j.1651-2227.1995.tb13795.x, PubMed 7488820

Publications 1994

Whitelaw A, Mowinckel MC, Larsen ML, Røkås E, Abildgaard U (1994)
Intraventricular streptokinase increases cerebrospinal fluid D dimer in preterm infants with posthaemorrhagic ventricular dilatation
Acta Paediatr, 83 (3), 270-2
DOI 10.1111/j.1651-2227.1994.tb18092.x, PubMed 8038528

Page visits: 5251